
    
      This is a prospective, open-label, consecutive interventional case series in treatment-na√Øve
      patients with exudative AMD. A loading phase of 2-3 injections is followed by a
      fixed-interval regimen of injections combined with a pro re nata regimen for 12 months.
      Endpoints include VA, presence of fluid at spectral domain optical coherent tomography
      (SD-OCT), adverse events and number of injections administered.
    
  